版本:
中国

BRIEF-Neothetics reports last subject enrolled in phase 2 proof of concept trial for lipo-202

March 20 Neothetics Inc:

* Neothetics announces last subject enrolled in phase 2 proof of concept trial for lipo-202 for the reduction of submental subcutaneous fat

* Expects to report top-line data in June 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐